Clint T. Allen found that Sema4D blockage improved responses to ICIs therapy for HNSCC patients due to repressing Ly6GhiLy6Cint MDSCs (PMN-MDSCs) infiltration by reducing MAPK-dependent expression of chemokines (44, 102). The gene discussed is SEMA4D; the disease is head and neck squamous cell carcinoma.